PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Medical Laboratory Center, General Hospital of the Central Theater Command, Wuhan, Hubei Province, People\'s Republic of China.\', \'Institute of Immunology, People\'s Liberation Army, Third Military Medical University, Chongqing, People\'s Republic of China.\', \'Department of Respiratory and Critical Medicine, General Hospital of the Central Theater Command, Wuhan, Hubei Province, People\'s Republic of China.\', \'Intensive Care Unit, General Hospital of Central Theater Command, Wuhan, Hubei Province, People\'s Republic of China.\', \'Intensive Care Unit, Wuhan Pulmonary Hospital, Wuhan, Hubei Province, People\'s Republic of China.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1093/cid/ciaa630
?:doi
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 32442287
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Thymosin Alpha 1 Reduces the Mortality of Severe Coronavirus Disease 2019 by Restoration of Lymphocytopenia and Reversion of Exhausted T Cells.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all